Vigil Neuroscience, Inc.

NasdaqGS:VIGL Stock Report

Market Cap: US$74.7m

Vigil Neuroscience Future Growth

Future criteria checks 2/6

Vigil Neuroscience is forecast to grow earnings and revenue by 30.6% and 59.9% per annum respectively. EPS is expected to grow by 39.9% per annum. Return on equity is forecast to be -135.5% in 3 years.

Key information

30.6%

Earnings growth rate

39.9%

EPS growth rate

Biotechs earnings growth26.8%
Revenue growth rate59.9%
Future return on equity-135.5%
Analyst coverage

Good

Last updated04 Dec 2024

Recent future growth updates

Recent updates

Vigil Neuroscience: Down On A Competitor's Failure

Dec 03

We Think Vigil Neuroscience (NASDAQ:VIGL) Needs To Drive Business Growth Carefully

Oct 17
We Think Vigil Neuroscience (NASDAQ:VIGL) Needs To Drive Business Growth Carefully

We're Keeping An Eye On Vigil Neuroscience's (NASDAQ:VIGL) Cash Burn Rate

May 30
We're Keeping An Eye On Vigil Neuroscience's (NASDAQ:VIGL) Cash Burn Rate

Is Vigil Neuroscience (NASDAQ:VIGL) In A Good Position To Deliver On Growth Plans?

Feb 01
Is Vigil Neuroscience (NASDAQ:VIGL) In A Good Position To Deliver On Growth Plans?

Is Vigil Neuroscience (NASDAQ:VIGL) In A Good Position To Deliver On Growth Plans?

Oct 14
Is Vigil Neuroscience (NASDAQ:VIGL) In A Good Position To Deliver On Growth Plans?

Here's Why We're Not Too Worried About Vigil Neuroscience's (NASDAQ:VIGL) Cash Burn Situation

Jun 27
Here's Why We're Not Too Worried About Vigil Neuroscience's (NASDAQ:VIGL) Cash Burn Situation

Here's Why We're Not Too Worried About Vigil Neuroscience's (NASDAQ:VIGL) Cash Burn Situation

Mar 14
Here's Why We're Not Too Worried About Vigil Neuroscience's (NASDAQ:VIGL) Cash Burn Situation

Here's Why We're Not Too Worried About Vigil Neuroscience's (NASDAQ:VIGL) Cash Burn Situation

Nov 29
Here's Why We're Not Too Worried About Vigil Neuroscience's (NASDAQ:VIGL) Cash Burn Situation

Vigil draws bullish view at Wedbush on upcoming readout for lead asset

Sep 16

Vigil Neuroscience announces $75M PIPE financing

Aug 12

We're Hopeful That Vigil Neuroscience (NASDAQ:VIGL) Will Use Its Cash Wisely

Jul 25
We're Hopeful That Vigil Neuroscience (NASDAQ:VIGL) Will Use Its Cash Wisely

Is Vigil Neuroscience (NASDAQ:VIGL) In A Good Position To Invest In Growth?

Apr 10
Is Vigil Neuroscience (NASDAQ:VIGL) In A Good Position To Invest In Growth?

Earnings and Revenue Growth Forecasts

NasdaqGS:VIGL - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202772-86-81-1425
12/31/202614-108-96-1575
12/31/20250-97-94-948
12/31/2024N/A-83-80-618
9/30/2024N/A-83-49-49N/A
6/30/2024N/A-84-70-70N/A
3/31/2024N/A-83-70-70N/A
12/31/2023N/A-83-71-70N/A
9/30/2023N/A-79-73-72N/A
6/30/2023N/A-76-72-71N/A
3/31/2023N/A-73-70-69N/A
12/31/2022N/A-68-66-65N/A
9/30/2022N/A-63-66-65N/A
6/30/2022N/A-56-61-61N/A
3/31/2022N/A-50-53-53N/A
12/31/2021N/A-43-40-39N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: VIGL is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: VIGL is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: VIGL is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: VIGL's revenue (59.9% per year) is forecast to grow faster than the US market (9% per year).

High Growth Revenue: VIGL's revenue (59.9% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: VIGL is forecast to be unprofitable in 3 years.


Discover growth companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/06 21:55
End of Day Share Price 2025/01/03 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Vigil Neuroscience, Inc. is covered by 10 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Yatin SunejaGuggenheim Securities, LLC
Andrew FeinH.C. Wainwright & Co.
Lin TsaiJefferies LLC